Ramucirumab for the treatment of patients with gastric or gastroesophageal junction cancer in community oncology practices

Authors:
Publisher website
Google Scholar
Abstract
Limited real-world research has investigated ramucirumab for the treatment of patients with gastric or gastroesophageal junction (GEJ) cancer. This study was designed to describe ramucirumab monotherapy or combination therapy use in a community oncology practice setting.
Funding Information
  • Eli Lilly and Company

This publication has 9 references indexed in Scilit: